title: Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease.
abstract: The impact of the endogenous cannabinoids (AEA, 2-AG, PEA, and virodamine) on the immune cell expressed cannabinoid receptors (CB1, CB2, TRPV-1, and GPR55) and consequent regulation of immune function is an exciting area of research with potential implications in the prevention and treatment of inflammatory and autoimmune diseases. Despite significant advances in understanding the mechanisms through which cannabinoids regulate immune functions, not much is known about the role of endocannabinoids in the pathogenesis or prevention of autoimmune diseases. Inasmuch as CB2 expression on immune cells and its role has been widely reported, the importance of CB1 in immunological disorders has often been overlooked especially because it is not highly expressed on naive immune cells. Therefore, the current review aims at delineating the effect of endocannabinoids on CB1 receptors in T cell driven autoimmune diseases. This review will also highlight some autoimmune diseases in which there is evidence indicating a role for endocannabinoids in the regulation of autoimmune pathogenesis. Overall, based on the evidence presented using the endocannabinoids, specifically AEA, we propose that the peripheral CB1 receptor is involved in the regulation and amelioration of inflammation associated with autoimmune diseases.
authors.affiliation: a Department of Pathology, Microbiology, & Immunology , University of South Carolina School of Medicine , Columbia , SC , USA.
authors.forename: Jessica Margaret
authors.initials: JM
authors.lastname: Sido
authors.affiliation: a Department of Pathology, Microbiology, & Immunology , University of South Carolina School of Medicine , Columbia , SC , USA.
authors.forename: Prakash S
authors.initials: PS
authors.lastname: Nagarkatti
authors.affiliation: a Department of Pathology, Microbiology, & Immunology , University of South Carolina School of Medicine , Columbia , SC , USA.
authors.forename: Mitzi
authors.initials: M
authors.lastname: Nagarkatti
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology* / Q000473:pathology; D063388:Endocannabinoids / Q000378:metabolism*; D004789:Enzyme Activation / Q000276:immunology; D019693:Hepatitis, Autoimmune / Q000276:immunology* / Q000473:pathology; D006801:Humans; D051379:Mice; D009103:Multiple Sclerosis / Q000276:immunology* / Q000473:pathology; D043884:Receptor, Cannabinoid, CB1 / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D063388:Endocannabinoids; D043884:Receptor, Cannabinoid, CB1
keywords: 2-AG; T cell-mediated disease; anandamide; cannabinoid receptors; cannabinoids; endocannabinoid system